France wants to mix vaccines – Denmark considers the same

French residents under the age of 55 who have received the first jab of Astrazeneca's vaccine will get their second injection with a different vaccine.

President of France Emmanuel Macron | Photo: JEFF PACHOUD/AFP / POOL

Like French health authorities, the Danish Health Authority is considering offering Danes who have received the first jab of the Astrazeneca vaccine another type of vaccine for their second vaccination, according to a Thursday press release coming from the Danish health authorities.

In the press statement, the Danish Health Authority notes that the second and final vaccination of people having received their first vaccination via the Astrazeneca vaccine will either contain the Astrazeneca vaccination type or a different one.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

In a world of options, Genmab's CEO chose partnerships

In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.

Analyst predicts slow start for Leo Pharma's Adtralza in UK

The take-up of Leo Pharma’s atopic eczema drug Adtralza in the UK will be slow-going, according to analyst bureau Global Data, after the British institute NICE released draft guidance where it was not recommend it as a standard treatment in England and Wales.

Further reading

Related articles

Latest news

See all jobs